ホーム › 頭頸部扁平上皮癌 › カリフォルニア州 › Baldwin Park
Baldwin Park、CAにおける頭頸部扁平上皮癌の臨床試験
Baldwin Parkとその周辺地域（約30マイル以内）の拠点で、頭頸部扁平上皮癌に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
被験者募集中第1相
- City of Hope National Medical Center, Duarte · 4マイル先
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
被験者募集中第2相
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte · 4マイル先
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, Duarte · 4マイル先
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
被験者募集中第3相
- City of Hope, Duarte · 4マイル先
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
被験者募集中第1相
- City of Hope Cancer Center, Duarte · 4マイル先
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
被験者募集中観察研究
- City of Hope, Duarte · 4マイル先
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
被験者募集中第1相
- City of Hope Comprehensive Cancer Center, Duarte · 4マイル先
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
被験者募集中第1相
- City Of Hope Comprehensive Cancer Center /ID# 276550, Duarte · 4マイル先
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
被験者募集中第1/2相
- City of Hope, Duarte · 4マイル先
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
被験者募集中第1相
- City of Hope National Medical Center /ID# 276272, Duarte · 4マイル先
A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
被験者募集中第2/3相
- City of Hope National Medical Center, Duarte · 4マイル先
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
被験者募集中第1相
- City of Hope, Duarte · 4マイル先
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
被験者募集中第3相
- City of Hope, Duarte · 4マイル先
他の都市における頭頸部扁平上皮癌の試験
- Houston, TX47件の研究
- Los Angeles, CA42件の研究
- Boston, MA40件の研究
- New York City, NY39件の研究
- Nashville, TN39件の研究
- St. Louis, MO28件の研究
- Arlington, VA26件の研究
- Philadelphia, PA26件の研究
- Chicago, IL26件の研究
- Atlanta, GA24件の研究
- San Antonio, TX22件の研究
- New Haven, CT22件の研究
Baldwin Parkにおける他の研究
- 乳がん44件の研究
- 急性骨髄性白血病40件の研究
- 大腸癌37件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）34件の研究
- 前立腺がん30件の研究
- 転移性癌30件の研究
- 骨髄異形成症候群26件の研究
- 卵巣がん25件の研究
- 肺がん24件の研究
- 多発性骨髄腫23件の研究
- 胃癌22件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。